Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Symphonic Capital is a venture capital firm founded in 2022 by Sydney Thomas, based in Oakland, California. The firm specializes in early-stage startups, particularly those with a minimum viable product valued at $10 million or less. As of now, Symphonic Capital manages a fund size of $14 million and has built a portfolio of 17 companies. The firm emphasizes a collaborative approach to building sustainable businesses, providing operational guidance and support to founders throughout their growth journey.
Since its inception, Symphonic Capital has focused on addressing significant issues that impact a broad audience, particularly in the healthcare and fintech sectors. The firm aims to invest in companies that prioritize long-term success and meaningful impact over high valuations or rapid returns. Notable milestones include the successful launch of their debut fund, which closed in April 2025, and the establishment of a strong LP base that includes institutional investors.
Symphonic Capital invests in early-stage companies across various sectors, with a particular emphasis on health technology and financial technology. The firm seeks to address core problems affecting the majority of people, particularly in overlooked and marginalized communities. Their investment strategy is centered on long-term success and meaningful impact, rather than solely on high valuations or rapid returns. The firm typically invests in pre-seed and seed stage companies, with check sizes ranging from $100,000 to $250,000.
Symphonic Capital looks for startups that have a minimum viable product and are valued at $10 million or less. The firm prioritizes investments that promote health and wealth equity, focusing on businesses that tackle significant societal challenges. Their thesis emphasizes the importance of supporting founders who are addressing issues such as maternal health, mental health, and community finance, thereby creating a positive impact on underserved populations.
Symphonic Capital's portfolio includes a diverse range of companies that reflect its commitment to health and wealth equity. Notable portfolio companies include:
This diverse portfolio showcases Symphonic Capital's commitment to investing in companies that address core societal problems, particularly in health and finance.
Sydney Thomas - Founding General Partner. Sydney has a background in venture capital and has led multiple investments in health and fintech sectors. She is committed to supporting founders from overlooked communities and has been recognized for her contributions to promoting diversity in venture capital.
Shruti Shah - Co-General Partner. Shruti brings extensive experience in operational support and strategic guidance for early-stage startups. She has a strong track record in helping companies scale and navigate the complexities of growth.
To pitch to Symphonic Capital, founders should visit their website at symphoniccapital.com and submit their proposals through the provided channels. The firm prefers detailed decks that outline the startup's mission, market opportunity, and impact. Founders should expect a response within a few weeks, and warm introductions are encouraged to facilitate the process.
In March 2026, Symphonic Capital announced the successful closing of its debut fund, raising $13.5 million. This fund will focus on early-stage investments in health and wealth equity initiatives. The firm has been actively building its portfolio, recently adding notable startups such as Bump, Flourish Care, and Remynt, which address critical issues in maternal health and community finance.
Coverage of the fund launch has appeared in major publications including Fortune, AfroTech, and Venture Capital Journal, highlighting the firm's commitment to investing in impactful early-stage companies.
What are Symphonic Capital's investment criteria?
Symphonic Capital invests in early-stage companies, particularly in health technology and financial technology sectors. They focus on startups with a minimum viable product valued at $10 million or less, typically at the pre-seed and seed stages.
How can I apply or pitch to Symphonic Capital?
Founders can pitch their startups by visiting Symphonic Capital's website at symphoniccapital.com or by emailing hi@symphonic.vc. They encourage detailed presentations that highlight the startup's mission and impact.
What makes Symphonic Capital different from other venture firms?
Symphonic Capital emphasizes health and wealth equity, focusing on impactful early-stage companies that address significant societal challenges. Their collaborative approach provides operational guidance and support to founders throughout their growth journey.
What is the geographic scope of Symphonic Capital's investments?
The firm primarily invests in startups located in the United States, targeting companies that serve overlooked and marginalized communities.
What is the typical check size for investments?
Symphonic Capital typically invests between $100,000 and $250,000 in their portfolio companies.
What kind of post-investment involvement does Symphonic Capital have?
Symphonic Capital provides operational guidance and strategic support to its portfolio companies, helping founders navigate the challenges of early-stage growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.